200,000+ products from a single source!
sales@angenechem.com
Home > Pyridines > 205246-48-6
205246-48-6 | 2-Pyrrolidinone, 3-hydroxy-1-methyl-5-(3-pyridinyl)-, (5S)-
CAS No: 205246-48-6 Catalog No: AG0029Y2 MDL No:
Product Description
Catalog Number:
AG0029Y2
Chemical Name:
2-Pyrrolidinone, 3-hydroxy-1-methyl-5-(3-pyridinyl)-, (5S)-
CAS Number:
205246-48-6
Molecular Formula:
C10H12N2O2
Molecular Weight:
192.2145
IUPAC Name:
(5S)-3-hydroxy-1-methyl-5-pyridin-3-ylpyrrolidin-2-one
InChI:
InChI=1S/C10H12N2O2/c1-12-8(5-9(13)10(12)14)7-3-2-4-11-6-7/h2-4,6,8-9,13H,5H2,1H3/t8-,9?/m0/s1
InChI Key:
XOKCJXZZNAUIQN-IENPIDJESA-N
SMILES:
O=C1C(O)C[C@H](N1C)c1cccnc1
Properties
Complexity:
232
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
1
Defined Bond Stereocenter Count:
0
Exact Mass:
192.09g/mol
Formal Charge:
0
Heavy Atom Count:
14
Hydrogen Bond Acceptor Count:
3
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
192.218g/mol
Monoisotopic Mass:
192.09g/mol
Rotatable Bond Count:
1
Topological Polar Surface Area:
53.4A^2
Undefined Atom Stereocenter Count:
1
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.9
Literature
| Title | Journal |
|---|---|
| Variation in trans-3'-hydroxycotinine glucuronidation does not alter the nicotine metabolite ratio or nicotine intake. | PloS one 20130101 |
| CYP2A6- and CYP2A13-catalyzed metabolism of the nicotine Δ5'(1')iminium ion. | The Journal of pharmacology and experimental therapeutics 20121101 |
| Nicotine intake and smoking topography in smokers with bipolar disorder. | Bipolar disorders 20120901 |
| Simultaneous quantification of nicotine, cotinine, trans-3'-hydroxycotinine, norcotinine and mecamylamine in human urine by liquid chromatography-tandem mass spectrometry. | Clinica chimica acta; international journal of clinical chemistry 20120614 |
| CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people. | Pharmacogenetics and genomics 20120601 |
| Exposure and kinetics of polycyclic aromatic hydrocarbons (PAHs) in cigarette smokers. | Chemical research in toxicology 20120416 |
| Determination of biomarkers of tobacco smoke exposure in oral fluid using solid-phase extraction and gas chromatography-tandem mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120315 |
| Glucuronidation of trans-3'-hydroxycotinine by UGT2B17 and UGT2B10. | Pharmacogenetics and genomics 20120301 |
| A one-year monitoring of nicotine use in sport: frontier between potential performance enhancement and addiction issues. | Forensic science international 20111210 |
| Quantification of nicotine, cotinine, trans-3'-hydroxycotinine and varenicline in human plasma by a sensitive and specific UPLC-tandem mass-spectrometry procedure for a clinical study on smoking cessation. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20111115 |
| Systematic review of the relationship between the 3-hydroxycotinine/cotinine ratio and cigarette dependence. | Psychopharmacology 20111101 |
| Oral fluid nicotine markers to assess smoking status and recency of use. | Therapeutic drug monitoring 20111001 |
| Measurement of nicotine, cotinine and trans-3'-hydroxycotinine in meconium by liquid chromatography-tandem mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110715 |
| Nicotine and metabolites in paired umbilical cord tissue and meconium specimens. | Therapeutic drug monitoring 20110201 |
| Determination of the nicotine metabolites cotinine and trans-3'-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110201 |
| Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level. | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20110201 |
| Biomarkers increase detection of active smoking and secondhand smoke exposure in critically ill patients. | Critical care medicine 20110101 |
| Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data. | Trials 20110101 |
| Chinese 'low-tar' cigarettes do not deliver lower levels of nicotine and carcinogens. | Tobacco control 20101001 |
| Environmental and biological monitoring of exposures to PAHs and ETS in the general population. | Environment international 20101001 |
| Carbamazepine but not valproate induces CYP2A6 activity in smokers with mental illness. | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20101001 |
| Nicotine and metabolites in meconium as evidence of maternal cigarette smoking during pregnancy and predictors of neonatal growth deficits. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20100601 |
| Nicotine and its metabolites in amniotic fluid at birth--assessment of prenatal tobacco smoke exposure. | Human & experimental toxicology 20100501 |
| Estimation of nicotine dose after low-level exposure using plasma and urine nicotine metabolites. | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20100501 |
| Relations between toxicity and altered tissue distribution and urinary excretion of nicotine, cotinine, and hydroxycotinine after chronic oral administration of nicotine in rats. | Drug and chemical toxicology 20100401 |
| Quantitation of nicotine, its metabolites, and other related alkaloids in urine, serum, and plasma using LC-MS-MS. | Methods in molecular biology (Clifton, N.J.) 20100101 |
| [Effect of tobacco smoking on the course and degree of advancement inflammation in periodontal tissue]. | Annales Academiae Medicae Stetinensis 20100101 |
| Optimization and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of nicotine, cotinine, trans-3'-hydroxycotinine and norcotinine in human oral fluid. | Analytical and bioanalytical chemistry 20091201 |
| Simultaneous and sensitive measurement of nicotine, cotinine, trans-3'-hydroxycotinine and norcotinine in human plasma by liquid chromatography-tandem mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20091101 |
| Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers. | Clinical pharmacology and therapeutics 20090601 |
| Genetic and environmental influences on the ratio of 3'hydroxycotinine to cotinine in plasma and urine. | Pharmacogenetics and genomics 20090501 |
| [Development of analytical method for determination nicotine metabolites in urine]. | Przeglad lekarski 20090101 |
| Meconium nicotine and metabolites by liquid chromatography-tandem mass spectrometry: differentiation of passive and nonexposure and correlation with neonatal outcome measures. | Clinical chemistry 20081201 |
| Studies on a simultaneous analytical method of urinary nicotine and its metabolites, and their half-lives in urine. | Journal of UOEH 20080901 |
| Nicotine metabolism in pregnant and nonpregnant rabbits. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20080801 |
| Stability of the nicotine metabolite ratio in ad libitum and reducing smokers. | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20080601 |
| Quantification of nicotine, cotinine, trans-3'-hydroxycotinine, nornicotine and norcotinine in human meconium by liquid chromatography/tandem mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080215 |
| Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolism. | Clinical pharmacology and therapeutics 20080101 |
| Effect of nicotine and nicotine metabolites on angiotensin-converting enzyme in human endothelial cells. | Endothelium : journal of endothelial cell research 20080101 |
| Secondhand smoke exposure in Mexican discotheques. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20071001 |
| Respiratory retention of nicotine and urinary excretion of nicotine and its five major metabolites in adult male smokers. | Toxicology letters 20070910 |
| Nicotine metabolism and CYP2A6 activity in a population of black African descent: impact of gender and light smoking. | Drug and alcohol dependence 20070615 |
| CYP2B6 genotype does not alter nicotine metabolism, plasma levels, or abstinence with nicotine replacement therapy. | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20070601 |
| Assessment of prenatal tobacco smoke exposure by determining nicotine and its metabolites in meconium. | Human & experimental toxicology 20070601 |
| Urine nicotine metabolites and smoking behavior in a multiracial/multiethnic national sample of young adults. | American journal of epidemiology 20070415 |
| Sex-based and hormonal contraception effects on the metabolism of nicotine among adolescent tobacco-dependent smokers. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20070401 |
| Characterization and comparison of nicotine and cotinine metabolism in vitro and in vivo in DBA/2 and C57BL/6 mice. | Molecular pharmacology 20070301 |
| Population pharmacokinetics of nicotine and its metabolites I. Model development. | Journal of pharmacokinetics and pharmacodynamics 20070201 |
| Prediction methods for nicotine clearance using cotinine and 3-hydroxy-cotinine spot saliva samples II. Model application. | Journal of pharmacokinetics and pharmacodynamics 20070201 |
| [Concentration of cotinine and trans-3'-hydroxycotinine and its glucuronides in urine of smoking pregnant women]. | Przeglad lekarski 20070101 |
| A comparison of nicotine dose estimates in smokers between filter analysis, salivary cotinine, and urinary excretion of nicotine metabolites. | Psychopharmacology 20061201 |
| CYP2A6 genotype and the metabolism and disposition kinetics of nicotine. | Clinical pharmacology and therapeutics 20061101 |
| Effect of grapefruit juice on cytochrome P450 2A6 and nicotine renal clearance. | Clinical pharmacology and therapeutics 20061101 |
| CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking. | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20061001 |
| Urinary nicotine and its metabolites as a biomarker of exposure to environmental tobacco smoke. | Journal of UOEH 20060901 |
| A validated method for the determination of nicotine, cotinine, trans-3'-hydroxycotinine, and norcotinine in human plasma using solid-phase extraction and liquid chromatography-atmospheric pressure chemical ionization-mass spectrometry. | Journal of mass spectrometry : JMS 20060601 |
| Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. | Clinical pharmacology and therapeutics 20060601 |
| Within-subject variation of the salivary 3HC/COT ratio in regular daily smokers: prospects for estimating CYP2A6 enzyme activity in large-scale surveys of nicotine metabolic rate. | Journal of analytical toxicology 20060101 |
| Evaluation of urinary trans-3'-hydroxycotinine as a biomarker of children's environmental tobacco smoke exposure. | Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 20060101 |
| [Assessment of occurrence frequency of cotinine and trans-3'-hydroxycotinine in chosen body fluid samples]. | Przeglad lekarski 20060101 |
| Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect. | Schizophrenia research 20051115 |
| Usefulness of salivary trans-3'-hydroxycotinine concentration and trans-3'-hydroxycotinine/cotinine ratio as biomarkers of cigarette smoke in pregnant women. | Journal of analytical toxicology 20051001 |
| Simultaneous determination of nicotine, cotinine, norcotinine, and trans-3'-hydroxycotinine in human oral fluid using solid phase extraction and gas chromatography-mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050125 |
| Trans-3'-hydroxycotinine O- and N-glucuronidations in human liver microsomes. | Drug metabolism and disposition: the biological fate of chemicals 20050101 |
| Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. | Clinical pharmacology and therapeutics 20040701 |
| N-glucuronidation of trans-3'-hydroxycotinine by human liver microsomes. | Chemical research in toxicology 20031201 |
| Nicotine metabolite ratio as a predictor of cigarette consumption. | Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20031001 |
| Plasma cotinine, 3'-hydroxycotinine, and their glucuronides in white and black smokers. | Journal of clinical psychopharmacology 20030401 |
| Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles. | Clinical chemistry 20020901 |
| Effects of whole deletion of CYP2A6 on nicotine metabolism in humans. | Drug and chemical toxicology 20020501 |
| [The intranatal analysis of trans-3'-hydroxycotinine concentrations in serum of mother and neonate exposed to tobacco smoke]. | Wiadomosci lekarskie (Warsaw, Poland : 1960) 20020101 |
| Bacterial mutagenicity of some tobacco aromatic nitrogen bases and their mixtures. | Mutation research 20010531 |
| Trans-3'-hydroxycotinine: disposition kinetics, effects and plasma levels during cigarette smoking. | British journal of clinical pharmacology 20010101 |
Related Products
© 2019 Angene International Limited. All rights Reserved.